1. Home
  2. The University Of North Carolina At Chapel Hill Patent Portfolio Statistics

The University Of North Carolina At Chapel Hill Patent Portfolio Statistics

The University Of North Carolina At Chapel Hill

The University Of North Carolina At Chapel Hill`s Profile

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of The University Of North Carolina At Chapel Hill look like?

Total Applications: 924
Granted Patents: 482
Grant Index 68.08 %
Abandoned/Rejected Applications: 226 (31.92%)
In-Process Applications: 216
Average Grant Time: 2.9 Years
Average Office Actions: 1.74

Which Technology Area The University Of North Carolina At Chapel Hill is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
Opap Parked GAU 60
1634 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 35
1648 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 35
2881 Optics 35
1633 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 32

How many patents are The University Of North Carolina At Chapel Hill filing every year?

Year Total Applications
2022 0*
2021 40*
2020 67
2019 66
2018 87

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of The University Of North Carolina At Chapel Hill in USPTO?

Publication number:

Abstract:
None

Publication date:
Applicant: The University Of North Carolina At Chapel Hill
Inventors: Kevin M Woeppel


Publication number: US20220025335A1

Abstract:
A Muscular Dystrophy Chimeric Cell generated by ex vivo fusion of a myoblast with a second myoblast, mesenchymal stem cell, or stromal cell is described as is the use of the same in the treatment of a muscular dystrophy.

Publication date: 2022-01-27
Applicant: The University Of North Carolina At Chapel Hill
Inventors: Maria Siemionow


Publication number: US20220025401A1

Abstract:
Adeno-associated virus rh.20 sequences, vectors containing same, and methods of use are provided.

Publication date: 2022-01-27
Applicant: The University Of North Carolina At Chapel Hill
Inventors: James M Wilson


How are The University Of North Carolina At Chapel Hill’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17605718 Use Of Nanoparticles To Stabilize And Preserve The Bioactivity Of Proteins And Peptides Sent to Classification contractor OPAP Central, Docket
17498901 Muscular Dystrophy Chimeric Cells And Method For Treating Muscular Dystrophies OPAP Central, Docket
17499555 Method Of Detecting And/Or Identifying Adeno-Associated Virus (Aav) Sequences And Isolating Novel Sequences Identified Thereby 1648 Salvoza, M Franco G
17499567 Adeno-Associated Virus (Aav) Clades, Sequences, Vectors Containing Same, And Uses Therefor 1633 Marvich, Maria
17498440 Parallel Data Processing For Service Function Chains Spanning Multiple Servers OPAP Central, Docket